Drug-induced changes in cortical inhibition in medication overuse headache

Cephalalgia

Volumn 31, Issue 12, 2011, Pages 1282-1290

  Currà, Antonio ^a   Coppola, Gianluca ^b   Gorini, Manuela ^a   Porretta, Elisa ^a   Bracaglia, Martina ^a   Di Lorenzo, Cherubino ^c   Schoenen, Jean ^d   Pierelli, Francesco ^a,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e IRCCS NEUROMED   (Italy)

Author keywords

cortical inhibition; Medication overuse headache; NSAIDs; silent period; transcranial magnetic stimulation; triptans

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INDUCED HEADACHE; FEMALE; HUMAN; INHIBITION KINETICS; MALE; NEUROTRANSMISSION; PRIMARY MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EVOKED POTENTIALS, MOTOR; FEMALE; HEADACHE; HUMANS; MALE; MOTOR CORTEX; NEURAL INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION; TRYPTAMINES;

EID: 80052797570     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411415877     Document Type: Article

References (43)

1. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
2. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol. 2006 ; 13: 333-345
3. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004 ; 62: 788-790 (Pubitemid 38298959)
4. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004 ; 24: 483-490 (Pubitemid 38748030)
5. Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci. 2005 ; 26: 62-68 (Pubitemid 40170167)
6. Supornsilpchai W, le Grand SM, Srikiatkhachorn A. Cortical hyperexcitability and mechanism of medication-overuse headache. Cephalalgia. 2010 ; 30: 1101-1109
7. Supornsilpchai W, le Grand SM, Srikiatkhachorn A. Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache. Headache. 2010 ; 50: 185-197
8. Currà A, Modugno N, Inghilleri M, Manfredi M, Hallett M, Berardelli A. Transcranial magnetic stimulation techniques in clinical investigation. Neurology. 2002 ; 59: 1851-1859 (Pubitemid 36076554)
9. Chen R. Studies of human motor physiology with transcranial magnetic stimulation. Muscle Nerve Suppl. 2000 ; 9: S26 - S32
10. Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology. 1992 ; 42: 1951-1959
11. Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol. 1991 ; 81: 257-262
12. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol. 1999 ; 517: 591-597 (Pubitemid 29296371)
13. Leis AA, Kofler M, Stokic DS, Grubwieser GJ, Delapasse JS. Effect of the inhibitory phenomenon following magnetic stimulation of cortex on brainstem motor neuron excitability and on the cortical control of brainstem reflexes. Muscle Nerve. 1993 ; 16: 1351-1358 (Pubitemid 23351087)
14. Cruccu G, Inghilleri M, Berardelli A, Romaniello A, Manfredi M. Cortical mechanisms mediating the inhibitory period after magnetic stimulation of the facial motor area. Muscle Nerve. 1997 ; 20: 418-424 (Pubitemid 27154631)
15. Curra A, Pierelli F, Coppola G, Barbanti P, Buzzi MG, Galeotti F, et al. Shortened cortical silent period in facial muscles of patients with migraine. Pain. 2007 ; 132: 124-131 (Pubitemid 47494565)
16. Schoenen J. Deficient habituation of evoked cortical potentials in migraine: a link between brain biology, behavior and trigeminovascular activation?. Biomed Pharmacother. 1996 ; 50: 71-78 (Pubitemid 26116392)
17. Coppola G, Vandenheede M, Di Clemente L, Ambrosini A, Fumal A, De Pasqua V, et al. Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks. Brain. 2005 ; 128: 98-103 (Pubitemid 40070524)
18. Cruccu G, Berardelli A, Inghilleri M, Manfredi M. Corticobulbar projections to upper and lower facial motoneurons. A study by magnetic transcranial stimulation in man. Neurosci Lett. 1990 ; 117: 68-73 (Pubitemid 20284076)
19. Smith MJ, Keel JC, Greenberg BD, Adams LF, Schmidt PJ, Rubinow DA, et al. Menstrual cycle effects on cortical excitability. Neurology. 1999 ; 53: 2069-2072
20. Werhahn KJ, Förderreuther S, Straube A. Effects of the serotonin1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology. 1998 ; 51: 896-898 (Pubitemid 28449286)
21. Proietti-Cecchini A, Afra J, Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia. 1997 ; 17: 849-854
22. Zank R, Strehl U, Larbig W, Kotchoubey B. Effects of rizatriptan on the contingent negative variation in healthy women. Cephalalgia. 2008 ; 28: 922-932
23. Ayzenberg I, Obermann M, Nyhuis P, Gastpar M, Limmroth V, Diener HC, et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia. 2006 ; 26: 1106-1114 (Pubitemid 44199402)
24. Dvorzhak AY. Effects of fenamate on inhibitory postsynaptic currents in Purkinje's cells. Bull Exp Biol Med. 2008 ; 145: 564-568
25. Fernández M, Lao-Peregrín C, Martín ED. Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability. Epilepsia. 2010 ; 51: 384-390
26. Geyer MA. Serotonergic functions in arousal and motor activity. Behav Brain Res. 1996 ; 73: 31-35 (Pubitemid 26008759)
27. Jacobs BL, Fornal CA. Serotonin and motor activity. Curr Opin Neurobiol. 1997 ; 7: 820-825 (Pubitemid 28052305)
28. Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol. 2001 ; 50: 718-729 (Pubitemid 33116131)
29. Loubinoux I, Pariente J, Boulanouar K, Carel C, Manelfe C, Rascol O, et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. Neuroimage. 2002 ; 15: 26-36 (Pubitemid 34852202)
30. Ilic TV, Korchounov A, Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline. Neurosci Lett. 2002 ; 319: 116-120 (Pubitemid 34127944)
31. Pleger B, Schwenkreis P, Grünberg C, Malin JP, Tegenthoff M. Fluoxetine facilitates use-dependent excitability of human primary motor cortex. Clin Neurophysiol. 2004 ; 115: 2157-2163 (Pubitemid 39037305)
32. Gerdelat-Mas A, Loubinoux I, Tombari D, Rascol O, Chollet F, Simonetta-Moreau M. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage. 2005 ; 27: 314-322 (Pubitemid 41074834)
33. Pini LA, Sandrini M, Vitale G. Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat. Inflamm Res. 1995 ; 44: 30-35
34. Sandrini M, Vitale G, Pini LA. Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes. Pharmacology. 2002 ; 65: 193-197 (Pubitemid 34765280)
35. Ruggieri V, Vitale G, Filaferro M, Frigeri C, Pini LA, Sandrini M. The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats. Life Sci. 2010 ; 86: 510-517
36. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002 ; 71: 533-554 (Pubitemid 34219205)
37. Supornsilpchai W, Sanguanrangsirikul S, Maneesri S, Srikiatkhachorn A. Serotonin depletion, cortical spreading depression, and trigeminal nociception. Headache. 2006 ; 46: 34-39
38. Hering R, Glover V, Pattichis K, Catarci T, Steiner TJ. 5HT in migraine patients with medication-induced headache. Cephalalgia. 1993 ; 13: 410-412 (Pubitemid 24017457)
39. Srikiatkhachorn A, Anthony M. Platelet serotonin in patients with analgesic-induced headache. Cephalalgia. 1996 ; 16: 423-426 (Pubitemid 26338473)
40. Srikiatkhachorn A, Puangniyom S, Govitrapong P. Plasticity of 5-HT serotonin receptor in patients with analgesic-induced transformed migraine. Headache. 1998 ; 38: 534-539 (Pubitemid 28429342)
41. Benarroch EE. Serotonergic modulation of basal ganglia circuits: complexity and therapeutic opportunities. Neurology. 2009 ; 73: 880-886
42. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001 ; 57: 1694-1698 (Pubitemid 33055491)
43. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002 ; 59: 1011-1014